BUNKER KEVIN D. (Chief Operating Officer) sold 4.8% of their position (5K shares) of ZENTALIS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $150.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/20/2022ACC: 0001725160-22-000135
Officer· Chief Operating Officer
Since Apr 2020
-5K
Net shares
Net seller
$150.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
5K disposed
Non-Derivative Transactions1
Common Stock
Indirect
Shares
−5K
Price / share
$30.00
Trade value
$150K
% of position
4.8%
7/20/2022
105K→100K
Total
Net shares
−5K
Net value
-$150K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 7/20/2022 | S · Sale | −5K | $30.00 | $150K | 4.8% | 105K | 100K |
| Total | −5K | -$150K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned350.00
Common Stock
DirectShares owned764.11K
Total
764.11K direct·350.00 indirect764.46K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 350.00 | Indirect |
| Common Stock | 764.11K | Direct |
| Total | 764.46K | 764.11K direct·350.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported